Real-world outcomes of advanced melanoma patients not represented in phase III trials

Autor: van Zeijl, M C T, Ismail, R K, de Wreede, L C, van den Eertwegh, A J M, de Boer, A, van Dartel, M, Hilarius, D L, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Haanen, J B A G, Wouters, M W J M, Sub Algemeen Math. Inst, Afd Pharmacoepi & Clinical Pharmacology, extern UU GWS, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: International Journal of Cancer, 147(12), 3461-3470. Wiley-Liss Inc.
International Journal of Cancer
van Zeijl, M C T, Ismail, R K, de Wreede, L C, van den Eertwegh, A J M, de Boer, A, van Dartel, M, Hilarius, D L, Aarts, M J B, van den Berkmortel, F W P J, Boers-Sonderen, M J, de Groot, J-W B, Hospers, G A P, Kapiteijn, E, Piersma, D, van Rijn, R S, Suijkerbuijk, K P M, Ten Tije, A J, van der Veldt, A A M, Vreugdenhil, G, Haanen, J B A G & Wouters, M W J M 2020, ' Real-world outcomes of advanced melanoma patients not represented in phase III trials ', International Journal of Cancer, vol. 147, no. 12, pp. 3461-3470 . https://doi.org/10.1002/ijc.33162
International Journal of Cancer, 147(12), 3461. Wiley-Liss Inc.
International Journal of Cancer, 147, 3461-3470
International Journal of Cancer, 147, 12, pp. 3461-3470
International Journal of Cancer, 147(12), 3461-3470. Wiley
International Journal of Cancer, 147(12), 3461-3470. WILEY

The aim was to provide evidence on systemically treated patients with advanced melanoma not represented in phase III trials to support clinical decision‐making. Analysis were performed on advanced melanoma patients diagnosed between 2014 and 2017 i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed76ac9413719b51176ab36de68bd351
https://dspace.library.uu.nl/handle/1874/408494

END-OF-LIFE CARE IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

Autor: Leeneman, B., Franken, M., Aarts, M. J., van Akkooi, A. C., van den Berkmortel, F. W., van den Eertwegh, A. J., de Groot, J. W., Herbschleb, K. H., van der Hoeven, K. J., Hospers, G. A., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P., ten Tije, A. J., van der Veldt, A. A., Vreugdenhil, G., Wouters, M. W., van Zeijl, M. C., Haanen, J. B., Uyl-de Groot, C. A.

Publikováno v: Value in Health, 21(Suppl.3):PCN220, S51-S51. ELSEVIER SCIENCE INC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::235939270fbc1fb67920308645149439
https://hdl.handle.net/1887/122836

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.